Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a global pharmaceutical leader focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.
Employees: 11-50
Founded date: 1987
Investors 1
| Date | Name | Website |
| 07.08.2021 | New Enterp... | nea.com |
Mentions in press and media 1
| Date | Title | Description |
| 17.07.2017 | FDA keeps a firm grip on partial hold for troubled Repros Therapeutics, with big trial demand | The news isn’t getting any better at Repros Therapeutics $RPRX. Early Monday the Woodlands, TX-based biotech put out the word that the partial hold placed on the Proellex program will remain in place after regulators made cl... |